Alvotech (ALVO) EBITDA Margin (2022 - 2026)
Alvotech's (ALVO) quarterly EBITDA Margin came in at 18.9% in Q1 2026, down 5647.0% YoY from 0.34% in Q1 2025, and down 97.61% on a QoQ basis from 790.72% in Q4 2025.
Alvotech (ALVO) EBITDA Margin (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has 5 years of EBITDA Margin data on file, last reported at 18.9% in Q1 2026.
- Quarterly EBITDA Margin fell 5647.0% year-over-year to 18.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.32% (up 40118.0% YoY) and the FY2025 annual result came in at 28.31%, up 284.0% from the prior year.
- EBITDA Margin slipped to 18.9% in Q1 2026, from 790.72% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 790.72% in Q4 2025 to a low of 15988.05% in Q1 2022.
- A 5-year average of 1739.58% and a median of 390.06% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin jumped 1538118 bps — and 2025, when it plunged 132854 bps.
- Tracing ALVO's EBITDA Margin over 5 years: stood at 2514.82% in 2022, then gained by 25 bps to 1877.67% in 2023, then surged by 85 bps to 291.02% in 2024, then surged by 372 bps to 790.72% in 2025, then plunged by 98 bps to 18.9% in 2026.
- The last three EBITDA Margin figures came in at 18.9% (Q1 2026), 790.72% (Q4 2025), and 929.24% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.22 Bn | 1.22 Bn | 5.09 Mn | 18.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.90% |
| Dec 31, 2025 | 790.72% |
| Sep 30, 2025 | -929.24% |
| Jun 30, 2025 | -9.22% |
| Mar 31, 2025 | 75.37% |
| Dec 31, 2024 | -291.02% |
| Sep 30, 2024 | 399.30% |
| Jun 30, 2024 | -390.06% |
| Mar 31, 2024 | -389.53% |
| Dec 31, 2023 | -1,877.67% |
| Jun 30, 2023 | -608.07% |
| Mar 31, 2023 | -606.87% |
| Dec 31, 2022 | -2,514.82% |
| Jun 30, 2022 | -3,773.51% |
| Mar 31, 2022 | -15,988.05% |